The Cumming Global Centre for Pandemic Therapeutics was established in Melbourne’s biomedical precinct in recognition of the state of Victoria’s global standing as a leader in biomedical research and learning.
Positioning the Centre within the precinct will accelerate research translation and commercialisation through proximity to potential partners including biopharma companies, research institutes, hospitals, and specialist facilities and services such as: clinical trials, antiviral screening and molecular structural analysis.
The Cumming Global Centre is established within the Doherty Institute located in the Melbourne Biomedical Precinct and will form part of the $650M Australian Institute for Infectious Disease (AIID), which has been funded by the Victorian Government and is set to open in 2027.
-
Australian Institute for Infectious Disease
Designed to protect Australia and the region against infectious disease and future pandemics, the AIID involves establishing a Victoria-wide alliance with the Burnet Institute and the University of Melbourne in delivering a new purpose-built facility in the biomedical precinct.